Skip to content

Crossed versus conventional pseudophakic monovision for high myopic eyes

Crossed versus conventional pseudophakic monovision for high myopic eyes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030935
Enrollment
Unknown
Registered
2020-03-18
Start date
2018-11-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catara, myopia

Interventions

Conventional Monovision Group:In the conventional monovision group with patients whose refraction was targeted to -0.50D in the dominant eye and -2.00D in the non-dominant eye.
Crossed Monovision Group:the crossed monovision group was assigned with patients whose refraction was targeted to -2.00D in the dominant eye and -0.50D in the non-dominant eye.

Sponsors

Department of Ophthalmology of the First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
39 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with myopic diopter greater than -6.0D (including -6.0D), axial length greater than 26.00mm (including 26.00mm), and lens opacification that affecting life quality, who had strong desire of spectacle independent, have been included in this study.

Exclusion criteria

Exclusion criteria: The exclusion criteria included any other ocular pathological conditions that would affected the visual acuity after surgery, such as dysfunction of optic nerve, macula, retina or cornea; severe ocular opaque other than cataract; history of non-cataract ocular surgery or inflammation; eyes planned for extracapsular cataract extraction; intractable synechia of iris; strabismus; patients refusal or any difficulty during examination or follow-up.

Design outcomes

Primary

MeasureTime frame
BUDVA;BUNVA;BCDVA;BCNVA;contrast visual acuity;stereoacuity;Questionnaires;

Countries

China

Contacts

Public ContactKe Hu

Department of Ophthalmology of the First Affiliated Hospital of Chongqing Medical University

42222@qq.com+86 13996314848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026